Herbal compositions and treatment methods

Patent 6841174 Issued on January 11, 2005. Estimated Expiration Date:

September 19, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Extract solution and herbal mixture for treatment of hepatitis
Patent #: 5648089
Issued on: 07/15/1997
Inventor: Shawkat

Organic electroluminescent device hermetic encapsulation package and method of fabrication
Patent #: 5874804
Issued on: 02/23/1999
Inventor: Rogers

Natural composition extracted from plants used in the treatment of cancer Patent #: 5876728
Issued on: 03/02/1999
Inventor: Kass, et al.

Inventors

Assignee

Zeyad Technologies LLC

Application

No. 09955877 filed on 09/19/2001

US Classes:

424/725, PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)424/773, Containing or obtained from a root, bulb, tuber, corm, or rhizome (aka radix)424/774, Containing or obtained from a leaf (aka folium or foliage)424/775, Containing or obtained from a bark (aka cortex)424/776, Containing or obtained from a seed or nut424/777, Containing or obtained from a fruit (aka fructus), including berry424/779, Containing or obtained from a stem, stalk, branch, or twig, (aka ramus or ramulus)424/434Mucosal (e.g., nasal, etc.)

Examiners

Primary: Patten, Patricia

Attorney, Agent or Firm

Baker Botts L.L.P.

Foreign Patent References

793964 EP 09/01/1999

International Class

A61K 3578

Abstract

The invention provides herbal compositions with antiviral properties comprising extracts of Foeniculum vulgare, Nigella sativa, Centaurium erythrae (spicatum or pulchellum), Cynara cardunculus var scolymus, Inula helenium (viscosa), Solenostema argel, Sesbania aegyptiaca (sesban), Cichorium intybus (pumilum), Cymbopogon proximus, Hemidesmus indicus, Rheum officinale, Cuminum cyminum, and combinations thereof. The invention further provides herbal compositions with antiviral properties comprising an extract from the leaves or seed of Sesbania aegyptiaca (sesban) and at least one additional herbal extract selected from the group consisting of seed of Nigella sativa, shoot of Cichorium intybus (pumilum), whole plant of Cymbopogon proximus, rhizome of Hemidesmus indicus, leaves of Solenostema argel, rhizome of Rheum officinale, and fruit of Ecballium elaterium. The present invention also provides methods for treating a subject with a viral infection, particularly infections with hepatitis B virus or hepatitis C virus. The methods comprise administering to a subject an effective amount of a herbal composition selected from among the herbal compositions of the invention.

Other References

Revilla et al. Comparison of Several Procedures Used for the Extraction of Anthocyanins from Red Grapes; J. Agric. Food Chem, 1998, 46, 4592-4597.*
Mylonakis et al. Plasma Viral Load Testing in the Management of HIV Infection; American Family Physician; Feb. 2001, pp. 1-7.*
HIV/AIDS Monitoring; Improved Viral Load Test Approved by FDA; Blood Weekly; Atlanta; Sep. 2002 pp. 1-2.*
Animal Models (HBV0; Trimera Disease Model Developed for Hepatitis B; Cancerweekly Plus; Atlanta; 2/199 pp. 1-2.*
Davis, G. Treatment of Chronic Hepatitis C; British Medical Journal; Nov. 2001 pp. 1-3.*
Harvard School of Public Health Jan. 2004, -id=673>.
Buckwold, Beer, Donis, 2003 “Bovine viral diarrhea as a surrogate model of hepatitis C virus for the evaluation of anti-viral agents” Antiviral Research vol. 60(1):1-15;
Cost of Developing a New Drug Increases to About $1.7 Billion By Peter Landers, Wall Street Journal Dec. 8, 2003 .
Abramowicz M, ed., “Enfuviritide (Fuzeon) for HIV Infection” Med Lett Drugs Ther. 2003 Jun. 23; 45(1159): 49-50.
El-Awady, et al., Clinica Chimica Acta, 283(1-2);1-14 (1999).
McHutchison et al., “Interferon Alpha-2b Alone or in Combination with Ribavirin as Initial Treatment fro Chronic Hepatitis C”, New England Journal of Medicine vol. 339 No. 21 Nov. 19, 1998, 1485-1492;
Yokozawa, et al., J. Traditional Medicine, 15(1):45-51 (1998).
Alter, M.J., Hepatology, 26(1):62S-65S (1997).
Alam, et al., Phytotherapy Research, 10(1):58-61 (1996).
D.S. Chen; J. Formos. Med. Assoc., 95(1):6-12 (1996).
Detre, et al., Viral Hepatitis Rev., 2:219-228 (1996).
D.C. Dale and D.D. Federman, eds., Sci. Amer. Medicine, New York, 4(8):1-10 (1996).
Hibbs, et al., J. Infect. Dis. 168:789-790 (1993).
Lok, et al., Gastroenterology, 105(6):1833-1838 (1993).
Flint SJ et al., Principles of Virology: Molecular Biology, Pathogenesis, and Control, ASM Press, Washington DC, 1990, p. 691.
Medicinal Plants of North Africa, Loutfy Boulos, Reference Publications, Inc., pp. 150-51 (1983).
Medicinal Plants of North Africa, pp. 74-75, 92-93 (1983).
Bergmeyer and Horder, Clinica Chemica Acta 105:147f-154f (1980).
Encyclopedia of Common Natural Ingredients, Used in Food, Drugs, and Cosmetics, John Wiley & Sons, New York, p. 169 (1980).
International Federation of Clinical Chemistry, Scientific Committee, J. Clin. Chem. Clin. Biochem., 18521-534 (1980).
Bergmeyer H. U. Methods of Enzymatic Analysis. Verlag Chemic, (1978), pp. 130-135.
Babbar, et al.,Ind. J. Exp. Biol., 8:304-312 (1970).
Linus Pauling, General Chemistry, New York, Dover Publications, Inc., 1970, p. 744.